Scott Ullem - Edwards Lifesciences Co CFO

All Insiders . Germany . 
Stock . Edwards Lifesciences . Stakeholders . Insider . Scott Ullem
EWL Stock  EUR 70.08  0.26  0.37%   

Insider

Scott Ullem is Co CFO of Edwards Lifesciences
Age 56
Phone949 250 2500
Webhttps://www.edwards.com

Scott Ullem Latest Insider Activity

Tracking and analyzing the buying and selling activities of Scott Ullem against Edwards Lifesciences stock is an integral part of due diligence when investing in Edwards Lifesciences. Scott Ullem insider activity provides valuable insight into whether Edwards Lifesciences is net buyers or sellers over its current business cycle. Note, Edwards Lifesciences insiders must abide by specific rules, including filing SEC forms every time they buy or sell Edwards Lifesciences'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
 
Scott Ullem over six months ago
Disposition of 5625 shares by Scott Ullem of Edwards Lifesciences at 45.2767 subject to Rule 16b-3
 
Scott Ullem over six months ago
Disposition of 7250 shares by Scott Ullem of Edwards Lifesciences at 36.75 subject to Rule 16b-3
 
Scott Ullem over a year ago
Exercise or conversion by Scott Ullem of 1970 shares of Berry Global subject to Rule 16b-3
 
Scott Ullem over a year ago
Acquisition by Scott Ullem of 9000 shares of Berry Global subject to Rule 16b-3

Edwards Lifesciences Management Efficiency

The company has return on total asset (ROA) of 0.1334 % which means that it generated a profit of $0.1334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2614 %, meaning that it generated $0.2614 on every $100 dollars invested by stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.
Edwards Lifesciences has accumulated 596.3 M in total debt with debt to equity ratio (D/E) of 19.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Edwards Lifesciences has a current ratio of 3.59, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Edwards Lifesciences until it has trouble settling it off, either with new capital or with free cash flow. So, Edwards Lifesciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Edwards Lifesciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Edwards to invest in growth at high rates of return. When we think about Edwards Lifesciences' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Zelko RelicAlign Technology
58
Christopher TothSiemens Healthineers AG
44
Andre HartungSiemens Healthineers AG
N/A
MSc MDMedtronic PLC
N/A
Shirley StacyAlign Technology
N/A
Marc KoebernickSiemens Healthineers AG
N/A
Sean LennonMedtronic PLC
N/A
Catherine JenningsBoston Scientific
N/A
Vamsi PudipeddiAlign Technology
51
Hubert AllenAbbott Laboratories
57
Jodi EddyBoston Scientific
50
Simon BeardAlign Technology
56
James YoungAbbott Laboratories
N/A
Julie ColettiAlign Technology
54
Jonathan MonsonBoston Scientific
N/A
Melissa BrotzAbbott Laboratories
N/A
Robert FunckAbbott Laboratories
62
Robert FordAbbott Laboratories
49
Joseph HoganAlign Technology
66
Carsten BertramSiemens Healthineers AG
N/A
Bernhard MontagSiemens Healthineers AG
54
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people. Edwards Lifesciences (EWL) is traded on Frankfurt Exchange in Germany and employs 17,300 people.

Management Performance

Return On Equity0.26
Return On Asset0.13

Edwards Lifesciences Leadership Team

Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Ullem, Co CFO
Larry Wood, Co Replacement
Mark Wilterding, VP Relations
Donald Bobo, Corp Devel
Todd Brinton, Co Officer
Arnold Pinkston, Corp Counsel
Dirksen Lehman, Co Affairs
Michael Mussallem, Chairman CEO
JeanLuc Lemercier, Middle Europe
Christine McCauley, Co HR

Edwards Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Edwards Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.26
Return On Asset0.13
Profit Margin0.28 %
Operating Margin0.33 %
Current Valuation43.48 B
Shares Outstanding608.31 M
Shares Owned By Insiders0.82 %
Shares Owned By Institutions86.92 %
Price To Earning45.19 X
Price To Book7.49 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Edwards Stock

Edwards Lifesciences financial ratios help investors to determine whether Edwards Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Edwards with respect to the benefits of owning Edwards Lifesciences security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY